TY - JOUR AU - Pasternak, R. C. AU - Smith, S. C. AU - Bairey-Merz, C. N. AU - Grundy, S. M. AU - Cleeman, J. I. AU - Lenfant, C. PY - 2002 DA - 2002// TI - ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins JO - Stroke VL - 33 UR - https://doi.org/10.1161/01.str.0000034125.94759.41 DO - 10.1161/01.str.0000034125.94759.41 ID - Pasternak2002 ER - TY - JOUR AU - Law, M. AU - Rudnicka, A. R. PY - 2006 DA - 2006// TI - Statin safety: a systematic review JO - Am J Cardiol VL - 97 UR - https://doi.org/10.1016/j.amjcard.2005.12.010 DO - 10.1016/j.amjcard.2005.12.010 ID - Law2006 ER - TY - JOUR AU - Graham, D. J. AU - Staffa, J. A. AU - Shatin, D. AU - Andrade, S. E. AU - Schech, S. D. AU - La Grenade, L. AU - Gurwitz, J. H. AU - Chan, K. A. AU - Goodman, M. J. AU - Platt, R. PY - 2004 DA - 2004// TI - Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs JO - JAMA VL - 292 UR - https://doi.org/10.1001/jama.292.21.2585 DO - 10.1001/jama.292.21.2585 ID - Graham2004 ER - TY - JOUR AU - Bruckert, E. AU - Hayem, G. AU - Dejager, S. AU - Yau, C. AU - Begaud, B. PY - 2005 DA - 2005// TI - Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study JO - Cardiovasc Drugs Ther VL - 19 UR - https://doi.org/10.1007/s10557-005-5686-z DO - 10.1007/s10557-005-5686-z ID - Bruckert2005 ER - TY - JOUR AU - Nichols, G. A. AU - Koro, C. E. PY - 2007 DA - 2007// TI - Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.08.022 DO - 10.1016/j.clinthera.2007.08.022 ID - Nichols2007 ER - TY - JOUR AU - Joy, T. R. AU - Hegele, R. A. PY - 2009 DA - 2009// TI - Narrative review: statin-related myopathy JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-12-200906160-00009 DO - 10.7326/0003-4819-150-12-200906160-00009 ID - Joy2009 ER - TY - JOUR AU - Kirchheiner, J. AU - Kudlicz, D. AU - Meisel, C. AU - Bauer, S. AU - Meineke, I. AU - Roots, I. AU - Brockmoller, J. PY - 2003 DA - 2003// TI - Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers JO - Clin Pharmacol Ther VL - 74 UR - https://doi.org/10.1016/S0009-9236(03)00121-8 DO - 10.1016/S0009-9236(03)00121-8 ID - Kirchheiner2003 ER - TY - JOUR AU - Ishikawa, C. AU - Ozaki, H. AU - Nakajima, T. AU - Ishii, T. AU - Kanai, S. AU - Anjo, S. AU - Shirai, K. AU - Inoue, I. PY - 2004 DA - 2004// TI - A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin JO - J Hum Genet VL - 49 UR - https://doi.org/10.1007/s10038-004-0188-6 DO - 10.1007/s10038-004-0188-6 ID - Ishikawa2004 ER - TY - JOUR AU - Ozaki, H. AU - Ishikawa, C. T. AU - Ishii, T. AU - Toyoda, A. AU - Murano, T. AU - Miyashita, Y. AU - Shirai, K. PY - 2005 DA - 2005// TI - Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis JO - J Clin Pharm Ther VL - 30 UR - https://doi.org/10.1111/j.1365-2710.2005.00633_1.x DO - 10.1111/j.1365-2710.2005.00633_1.x ID - Ozaki2005 ER - TY - JOUR AU - Wilke, R. A. AU - Moore, J. H. AU - Burmester, J. K. PY - 2005 DA - 2005// TI - Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage JO - Pharmacogenet Genomics VL - 15 UR - https://doi.org/10.1097/01213011-200506000-00007 DO - 10.1097/01213011-200506000-00007 ID - Wilke2005 ER - TY - JOUR AU - Frudakis, T. N. AU - Thomas, M. J. AU - Ginjupalli, S. N. AU - Handelin, B. AU - Gabriel, R. AU - Gomez, H. J. PY - 2007 DA - 2007// TI - CYP2D6*4 polymorphism is associated with statin-induced muscle effects JO - Pharmacogenet Genomics VL - 17 UR - https://doi.org/10.1097/FPC.0b013e328012d0a9 DO - 10.1097/FPC.0b013e328012d0a9 ID - Frudakis2007 ER - TY - JOUR AU - Keskitalo, J. E. AU - Kurkinen, K. J. AU - Neuvoneni, P. J. AU - Niemi, M. PY - 2008 DA - 2008// TI - ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin JO - Clin Pharmacol Ther VL - 84 UR - https://doi.org/10.1038/clpt.2008.25 DO - 10.1038/clpt.2008.25 ID - Keskitalo2008 ER - TY - JOUR AU - Niemi, M. PY - 2007 DA - 2007// TI - Role of OATP transporters in the disposition of drugs JO - Pharmacogenomics VL - 8 UR - https://doi.org/10.2217/14622416.8.7.787 DO - 10.2217/14622416.8.7.787 ID - Niemi2007 ER - TY - JOUR AU - Pasanen, M. K. AU - Neuvonen, M. AU - Neuvonen, P. J. AU - Niemi, M. PY - 2006 DA - 2006// TI - SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid JO - Pharmacogenet Genomics VL - 16 UR - https://doi.org/10.1097/01.fpc.0000230416.82349.90 DO - 10.1097/01.fpc.0000230416.82349.90 ID - Pasanen2006 ER - TY - JOUR AU - Link, E. AU - Parish, S. AU - Armitage, J. AU - Bowman, L. AU - Heath, S. AU - Matsuda, F. AU - Gut, I. AU - Lathrop, M. AU - Collins, R. PY - 2008 DA - 2008// TI - SLCO1B1 variants and statin-induced myopathy - a genomewide study JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0801936 DO - 10.1056/NEJMoa0801936 ID - Link2008 ER - TY - JOUR AU - Voora, D. AU - Shah, S. H. AU - Spasojevic, I. AU - Ali, S. AU - Reed, C. R. AU - Salisbury, B. A. AU - Ginsburg, G. S. PY - 2009 DA - 2009// TI - The SLCO1B1 *5 genetic variant is associated with statin-induced side effects JO - J Am Coll Cardiol VL - 54 UR - https://doi.org/10.1016/j.jacc.2009.04.053 DO - 10.1016/j.jacc.2009.04.053 ID - Voora2009 ER - TY - JOUR AU - Morimoto, K. AU - Oishi, T. AU - Ueda, S. AU - Ueda, M. AU - Hosokawa, M. AU - Chiba, K. PY - 2004 DA - 2004// TI - A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy JO - Drug Metab Pharmacokinet VL - 19 UR - https://doi.org/10.2133/dmpk.19.453 DO - 10.2133/dmpk.19.453 ID - Morimoto2004 ER - TY - JOUR AU - Furihata, T. AU - Satoh, N. AU - Ohishi, T. AU - Ugajin, M. AU - Kameyama, Y. AU - Morimoto, K. AU - Matsumoto, S. AU - Yamashita, K. AU - Kobayashi, K. AU - Chiba, K. PY - 2009 DA - 2009// TI - Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy JO - Pharmacogenomics J VL - 9 UR - https://doi.org/10.1038/tpj.2009.3 DO - 10.1038/tpj.2009.3 ID - Furihata2009 ER - TY - JOUR AU - Fiegenbaum, M. AU - da Silveira, F. R. AU - Sand, C. R. V. a. n. d. e. r. AU - Sand, L. C. V. a. n. d. e. r. AU - Ferreira, M. E. AU - Pires, R. C. AU - Hutz, M. H. PY - 2005 DA - 2005// TI - The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment JO - Clin Pharmacol Ther VL - 78 UR - https://doi.org/10.1016/j.clpt.2005.08.003 DO - 10.1016/j.clpt.2005.08.003 ID - Fiegenbaum2005 ER - TY - JOUR AU - Vladutiu, G. D. PY - 2008 DA - 2008// TI - Genetic predisposition to statin myopathy JO - Curr Opin Rheumatol VL - 20 UR - https://doi.org/10.1097/BOR.0b013e328314b7b4 DO - 10.1097/BOR.0b013e328314b7b4 ID - Vladutiu2008 ER - TY - JOUR AU - Vladutiu, G. D. AU - Simmons, Z. AU - Isackson, P. J. AU - Tarnopolsky, M. AU - Peltier, W. L. AU - Barboi, A. C. AU - Sripathi, N. AU - Wortmann, R. L. AU - Phillips, P. S. PY - 2006 DA - 2006// TI - Genetic risk factors associated with lipid-lowering drug-induced myopathies JO - Muscle Nerve VL - 34 UR - https://doi.org/10.1002/mus.20567 DO - 10.1002/mus.20567 ID - Vladutiu2006 ER - TY - JOUR AU - Haller, R. G. PY - 2000 DA - 2000// TI - Treatment of McArdle disease JO - Arch Neurol VL - 57 UR - https://doi.org/10.1001/archneur.57.7.923 DO - 10.1001/archneur.57.7.923 ID - Haller2000 ER - TY - JOUR AU - Tsivgoulis, G. AU - Spengos, K. AU - Karandreas, N. AU - Panas, M. AU - Kladi, A. AU - Manta, P. PY - 2006 DA - 2006// TI - Presymptomatic neuromuscular disorders disclosed following statin treatment JO - Arch Intern Med VL - 166 UR - https://doi.org/10.1001/archinte.166.14.1519 DO - 10.1001/archinte.166.14.1519 ID - Tsivgoulis2006 ER - TY - JOUR AU - Mantel-Teeuwisse, A. K. AU - Klungel, O. H. AU - Schalekamp, T. AU - Verschuren, W. M. AU - Porsius, A. J. AU - de Boer, A. PY - 2005 DA - 2005// TI - Suboptimal choices and dosing of statins at start of therapy JO - Br J Clin Pharmacol VL - 60 UR - https://doi.org/10.1111/j.1365-2125.2005.02367.x DO - 10.1111/j.1365-2125.2005.02367.x ID - Mantel-Teeuwisse2005 ER - TY - JOUR AU - Hirschhorn, J. N. AU - Lohmueller, K. AU - Byrne, E. AU - Hirschhorn, K. PY - 2002 DA - 2002// TI - A comprehensive review of genetic association studies JO - Genet Med VL - 4 UR - https://doi.org/10.1097/00125817-200203000-00002 DO - 10.1097/00125817-200203000-00002 ID - Hirschhorn2002 ER - TY - JOUR AU - Peters, B. J. AU - Klungel, O. H. AU - de Boer, A. AU - Maitland-van der Zee, A. H. PY - 2009 DA - 2009// TI - Genetic determinants of response to statins JO - Expert Rev Cardiovasc Ther VL - 7 UR - https://doi.org/10.1586/erc.09.83 DO - 10.1586/erc.09.83 ID - Peters2009 ER - TY - JOUR AU - Niemi, M. AU - Pasanen, M. K. AU - Neuvonen, P. J. PY - 2006 DA - 2006// TI - SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin JO - Clin Pharmacol Ther VL - 80 UR - https://doi.org/10.1016/j.clpt.2006.06.010 DO - 10.1016/j.clpt.2006.06.010 ID - Niemi2006 ER -